Innovative Pre-clinical Research
Synovo is a drug discovery company with a primary focus on inflammation and innate immune processes.
We are located in Tübingen, Germany which is both a major centre for basic research and also home to a vibrant bio-medical start-up scene.
We have two main business areas:
- we provide drug discovery services in pharmacology, medicinal chemistry and bioanalytics, and,
- we develop in-house novel therapeutics and related diagnostics
Our culture is focused on generating insight through inter-disciplinary, collaborative work with clients and partners.
Within our team of nearly 50 people we have specialists in synthetic chemistry, pharmacology, analytics, immunology, neurology and biochemistry. In addition, we have a broad network of research partners throughout the world collaborating with us in areas like basic disease mechanisms, drug formulation technology, surface modification and drug mode of action.
We welcome enquiries and we are proud of our reputation for helping colleagues and partners achieve their research goals.
Together with our colleagues from Amsterdam and Leiden, we have taken a closer look into the antiinfective and immunomodulating effects our in-house […]
After two years of absence the World Congress on Inflammation took place in person again and Synovo was happy to present two […]
One of our premier internal research projects involves the development of novel, selective inhibitors of Janus kinase 3, a compound class of […]
We believe in
- Research commitment. Users/patients focus. Quality and reliability.
- Respect and integrity. Work-life balance.
- Interdisciplinary team. Open and constant flow of knowledge.
- Collaborative leadership. Transparent networking.
- Flexibility and Creative Innovation. Challenge acceptance.
- Education and training. Modern and traditional methods.
- Personal growth and initiative.